Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 2 years ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
Consequences and Management of Excessive Ostial Stent Protrusion
Author(s): Arditya Damarkusuma Added: 2 years ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper… View more

Imaging & Diagnostics

Intervention
EuroPCR 25: The DANAMI-3-DEFER Trial
Author(s): Jacob Thomsen Lønborg Added: 10 months ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent… View more

Intervention

MI/ACS
PERFORMANCE II: Two-Year Outcomes
Author(s): William Gray Added: 11 months ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego… View more

Vascular Disease and Surgery
ACC 25: Optimizing DAPT Duration
Author(s): Hyo-Soo Kim Added: 1 year ago
ACC 25 - Findings from a stratified study investigating coronary stenting and bleeding risk suggest 3 months are the optimal duration of DAPT after PCI.Dr Hyo-Soo Kim (Seoul National University Hospital, KR) sits down to discuss the first randomized study stratifying patients receiving percutaneous coronary intervention with drug eluting stents according to bleeding risk based on the ARC HBR… View more

Anticoagulation

Intervention
EuroPCR 24: The ABILITY Study
Author(s): Roxana Mehran Added: 1 year ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024.The ABILITY study (NCT04236609) aimed to evaluate the efficacy and safety of the Abluminus DES+ Sirolimus Eluting Stent System (SES) as compared to the XIENCE Everolimus Eluting Coronary Stent System in diabetic patients eligible for percutaneous coronary… View more

Intervention
Fernando Alfonso
Research Area(s) / Expertise: Job title: Interventional cardiologist
Fernando Alfonso is an Interventional Cardiologist at the Cardiovascular Institute at San Carlos University Hospital in Madrid. His research interests include intracoronary diagnostic techniques and in-stent restenosis. He is the editor of 10 cardiology books and is on the Editorial Boards ofJournal of the American College of Cardiology,European Heart JournalandRevista española de cardiología. Dr… View more
View from the Thoraxcenter: What's Hot at EuroPCR 24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00… View more

Intervention
Saib Khogali
Research Area(s) / Expertise:

Structural Intervention

Coronary Interventions

 Job title: Consultant Interventional Cardiologist and Honorary Senior Clinical Lecturer. Coronary interventions and Lead for Structural Heart Intervention, New Cross Hospital, Wolverhampton, UK
Dr. Saib Khogali is a renowned Consultant Cardiologist at the Heart & Lung Centre, New Cross Hospital, Wolverhampton. He also serves as an Honorary Senior Clinical Lecturer at the University of Birmingham. As a key member of a specialist team, Dr. Khogali has been instrumental in launching and establishing a comprehensive coronary angioplasty and stenting program, as well as enhancing emergency… View more
Eberhard Grube
Research Area(s) / Expertise:

Structural Intervention

 Job title: Professor of Medicine, Chief of the Department of Cardiology and Angiology
Prof Eberhard Grube was born in 1944 in Hamburg, Germany. He pursued his medical education in Germany and later undertook advanced training in the United States, laying the foundation for a distinguished international career in cardiology and interventional medicine.Academic HistoryProf Grube studied medicine at the Rheinische Friedrich-Wilhelm University in Bonn, Germany, where he earned his… View more